Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Allotment

 This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- principle approval received from BSE on 30.11.2022, and the allotment of warrants dated 14th December 2022, the allotment of 3,20,667 equity shares of Rs.2/- in the Company's Equity Share Capital, on conversion of 3,20,667 Warrants, be and are hereby allotted to the person as mentioned below at a price of Rs.10/- per equity shares includes a premium of Rs.8/- per share: for which the Board of Directors have accorded their approval, at their meeting held on 27th May, 2023 Commenced at 01.00 P.M and Concluded at 02:00 P.M. 1. Mr. Pavan Sathvik Gilaka (Whole Time Director) 3,20,667 Total 3,20,667 As per the Regulation 169(2) of the SEBI (ICDR) Regulations, 2018, 25% of the allotment price has been paid by the above mentioned allottees in to the Bank account of the Company.
27-05-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Allotment

 This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- principle approval received from BSE on 30.11.2022, and the allotment of warrants dated 14th December 2022, the allotment of 3,20,667 equity shares of Rs.2/- in the Company's Equity Share Capital, on conversion of 3,20,667 Warrants, be and are hereby allotted to the person as mentioned below at a price of Rs.10/- per equity shares includes a premium of Rs.8/- per share: for which the Board of Directors have accorded their approval, at their meeting held on 27th May, 2023 Commenced at 01.00 P.M and Concluded at 02:00 P.M. 1. Mr. Pavan Sathvik Gilaka (Whole Time Director) 3,20,667 Total 3,20,667 As per the Regulation 169(2) of the SEBI (ICDR) Regulations, 2018, 25% of the allotment price has been paid by the above mentioned allottees in to the Bank account of the Company.
27-05-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Allotment

 This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- principle approval received from BSE on 30.11.2022, and the allotment of warrants dated 14th December 2022, the allotment of 2,82,135 equity shares of Rs.2/- in the Company's Equity Share Capital, on conversion of 2,82,135 Warrants, be and are hereby allotted to the person as mentioned below at a price of Rs.10/- per equity shares includes a premium of Rs.8/- per share: for which the Board of Directors have accorded their approval, at their meeting held on 25th May, 2023 Commenced at 01.00 P.M and Concluded at 01:45 P.M. Mr. Murali Meraga (Non-Promoter) - No. of Shares - 2,82,135 Total (No. of Shares) - 2,82,135 As per the Regulation 169(2) of the SEBI (ICDR) Regulations, 2018, 25% of the allotment price has been paid by the above mentioned allottees in to the Bank account of the Company.
25-05-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 30.05.2023

 VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Tuesday, 30.05.2023 at 04:00 P.M at Plot No 104 Ravindra Co-operative Housing Society Guttala Begumpet Shaikpet TG 500033 inter-alia to discuss the following: 1. To consider, approve and take on record the Financial Results of the company for the quarter and year ended 31st March, 2023. 2. To consider and take note of the Auditor's Report for the quarter and year ended 31st March, 2023 3. To approve the appointment of Secretarial Auditors of the Company for Financial Year 2022-23 4. To approve the appointment of Internal Auditors of the Company for the Financial Year 2023-24 5. To consider the appointment of Company Secretary and Compliance Officer of the Company
23-05-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Allotment

 This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- principle approval received from BSE on 30.11.2022, and the allotment of warrants dated 14th December 2022, the allotment of 2,17,115 equity shares of Rs.2/- in the Company's Equity Share Capital, on conversion of 2,17,115 Warrants, be and are hereby allotted to the person as mentioned below at a price of Rs.10/- per equity shares includes a premium of Rs.8/- per share: for which the Board of Directors have accorded their approval, at their meeting held on 8th May, 2023 Commenced at 04.00 P.M and Concluded at 05:00 P.M. Sl. No Name of the Allottee No of Equity Shares 1. Mr. Murali Meraga (Non-Promoter) 2,17,115 Total 2,17,115
08-05-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-Reg

 Pursuant to regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby submit the Compliance Certificate certifying that we are maintaining all the activities in relation to both physical and electronic share transfer maintained by Aarthi Consultants Private Limited for the year ended 31st March, 2023 for your records.
29-04-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Allotment

 This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- principle approval received from BSE on 30.11.2022, and the allotment of warrants dated 14th December 2022, the allotment of 7,20,035 equity shares of Rs.2/- in the Company's Equity Share Capital, on conversion of 7,20,035 Warrants, be and are hereby allotted to the person as mentioned below at a price of Rs.10/- per equity shares includes a premium of Rs.8/- per share: for which the Board of Directors have accorded their approval, at their meeting held on 24th April, 2023 Commenced at 05.00 P.M and Concluded at 05:30 P.M.
24-04-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 With reference to the subject matter cited and pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith certificate from Practicing Company Secretary for the year ended 31st March, 2023.
15-04-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 With reference to the above-mentioned subject matter, please find enclosed herewith certificate issued by Aarthi Consultants Private Limited, Registrar and Share Transfer Agent confirming the compliance of regulation 74 (5) of SEBI (Depository and Participants) Regulations, 2018 for the period from 01.01.2023 to 31.03.2023.
15-04-2023
Bigul

VISTA PHARMACEUTICALS LTD. - 524711 - Announcement under Regulation 30 (LODR)-Change in Corporate Office Address

 Pursuant to Regulation 30 of the SEBI Listing Regulations, we would like to inform you that consequent to the Resolution by Circulation passed by the Board of Diretors of the Company, dated February, 10 2023, for shifting of Corporate Office (place of maintenance of books of accounts other than Registered Office) of the Company from, 7-1-212/A/70, Plot No: 85, Shivbagh, Ameerpet, Hyderabad, Telangana- 500 016, India to Plot No: 104, 3rd Floor, Ravindra Co-operative Housing Society, Guttala Begumpet, Kakatiya Hills, Telangana 500033 , India with effect from 10.04.2023.
10-04-2023
Next Page
Close

Let's Open Free Demat Account